| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3268213 | Endocrinology and Metabolism Clinics of North America | 2009 | 12 Pages |
Abstract
Recent studies have shown the spectrum of dyslipidemia in patients who have chronic kidney disease (CKD) or end-stage renal disease to be different from that of the general population. This article discusses the pathophysiology of dyslipidemia in CKD, dialysis, and renal transplant patients, the therapeutic options, and their association with clinical outcomes. Whenever possible, comparisons are made to outcomes in the general population.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Terri MD, Barbara MD,